HealthTree Logo
search more_vert

Clinical Expertise

  • Multiple myeloma
  • Waldenstrom Macroglobulinemia
  • Blood & marrow transplantation

About

Jeffrey Matous, MD, is a Member Physician at the Colorado Blood Cancer Institute and part of the Plasma Cell Diseases Group. Dr. Matous became a member of CBCI in 2010. He is presently a clinical professor of medicine at the University of Colorado Health Sciences Center. Dr. Matous is also on the board of the Leukemia-Lymphoma Society.

Dr. Matous was born in Sarnia, Ontario, Canada but raised in Seattle, Washington. Dr. Matous received his medical degree with honors from the University of Washington. He completed his internal medicine residency and chief residency at the University of Colorado Health Sciences Center. His fellowship training in hematology and bone marrow transplantation was completed at the University of Washington and the Fred Hutchinson Cancer Research Center. He returned to Denver to practice at Rocky Mountain Cancer Centers in 1994, where he worked until 2010 before moving to CBCI.

Dr. Matous specializes in the treatment of blood cancers such as multiple myeloma, Waldenstrom Macroglobulinemia and amyloidosis as well as in the field of blood & marrow transplantation. Dr. Matous has a particular interest in medical education and supervises both medical students and internal medicine residents who are interested in the field of hematology/oncology. Dr. Matous has been recognized as an outstanding clinical teacher of the medicine house staff. He is the lead investigator in clinical trials in the areas of Waldenstrom’s Macroglobulinemia, multiple myeloma, and amyloidosis, and has been recognized by his peers as Top Doctor for the past 16 years. He is passionate about educating patients with these diseases.

Dr. Matous is married with three adult children. Outside of work he enjoys cycling, languages, and our nation’s pastime.

Location

Colorado Blood Cancer Institute: 1721 E 19th Ave Ste. 300, Denver, CO 80218, USA

Get the latest thought leadership on CLL delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for CLL Newsletter" for CLL news, life with CLL stories, CLL clinical trials, CLL 101 articles and events with CLL experts.